Asthma Trials in Leeuwarden, Netherlands
Conditions / Asthma / Leeuwarden, Netherlands
Asthma has been the subject of sustained clinical investigation across multiple research sites.
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02281318 | Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control | COMPLETED | PHASE3 |
| NCT02281357 | Phase 3 Study to Evaluate the Efficacy & Safety of Tralokinumab in Adults & Adolescents With OCS Dependent Asthma | COMPLETED | PHASE3 |
| NCT02537691 | Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers | COMPLETED | PHASE4 |
| NCT01842607 | A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects | COMPLETED | PHASE3 |
| NCT04718389 | A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype | COMPLETED | PHASE3 |
| NCT02555371 | Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients | COMPLETED | PHASE3 |
| NCT02501629 | An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils | COMPLETED | PHASE3 |
| NCT02563067 | Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. | COMPLETED | PHASE3 |
| NCT03052517 | Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment | TERMINATED | PHASE3 |
| NCT02135692 | A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects | COMPLETED | PHASE3 |